ECOR

+ Watchlist + Portfolio

electroCore, Inc.

Regulated industry Physical productsTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $10.32
52-Week Range: $4.41 – $12.70
Market Cap: $91.42M
P/E (TTM): —
EPS (TTM): -1.65
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: —
PEG Ratio: —
Return on Equity: —
Return on Assets: -55.00%
Gross Margin: 87.06%
Operating Margin: -29.33%
Profit Margin: -39.96%
Current Ratio: 1.21
Debt/Equity: —
Total Debt: $9.56M
Free Cash Flow: $-4.68M
Revenue Growth: 28.00%
Earnings Growth: —
Enterprise Value: $90.94M

ECOR Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$8.59M	$16.03M	$25.18M	$32.03M
Cost of Revenue	$1.62M	$2.80M	$3.79M	$4.24M
Gross Profit	$6.98M	$13.23M	$21.40M	$27.79M
Research & Development	$5.52M	$5.32M	$2.36M	$2.73M
Selling, General & Admin	$24.33M	$27.17M	$31.20M	$38.21M
Operating Expenses	$29.85M	$32.49M	$33.56M	$40.94M
Operating Income	-$22.87M	-$19.27M	-$12.16M	-$13.15M
EBITDA	-$22.28M	-$18.24M	-$10.33M	-$11.70M
Pretax Income	-$22.59M	-$19.02M	-$11.98M	-$13.96M
Income Tax	-$431.00K	-$186.00K	-$93.00K	$3.00K
Net Income	-$22.16M	-$18.83M	-$11.89M	-$13.97M
Diluted EPS	-4.69	-3.42	-1.59	-1.65
Diluted Shares	4.73M	5.51M	7.48M	8.48M

ECOR Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$17.71M	$10.33M	$3.70M	$7.04M
Receivables	$401.00K	$717.00K	$1.37M	$1.03M
Inventory	$1.98M	$2.16M	$1.68M	$1.63M
Current Assets	$21.17M	$14.29M	$16.30M	$15.67M
Total Assets	$24.76M	$16.10M	$20.47M	$18.67M
Current Liabilities	$7.04M	$8.12M	$9.15M	$11.35M
Long-Term Debt	—	—	—	$6.61M
Total Debt	$699.00K	$626.00K	$4.14M	$9.40M
Total Liabilities	$7.67M	$8.66M	$12.93M	$20.38M
Retained Earnings	-$146.37M	-$165.20M	-$177.09M	-$191.06M
Shareholders' Equity	$17.09M	$7.44M	$7.54M	-$1.71M
Working Capital	$14.13M	$6.17M	$7.15M	$4.32M

ECOR Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$16.64M	-$14.67M	-$6.95M	-$8.19M
Capital Expenditure	—	-$206.00K	—	-$66.00K
Free Cash Flow	-$16.64M	-$14.87M	-$6.95M	-$8.25M
Depreciation & Amortisation	$596.00K	$1.02M	$1.26M	$1.68M
Stock-Based Compensation	$2.68M	$1.70M	$1.87M	$1.93M
Investing Cash Flow	$0.00	-$206.00K	-$8.52M	$3.88M
Financing Cash Flow	$0.00	$7.49M	$8.44M	$7.63M
Dividends Paid	$0.00	$0.00	—	—
Net Change in Cash	-$16.64M	-$7.39M	-$7.03M	$3.32M

ECOR Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$6.72M	$7.38M	$8.69M	$9.24M	$9.58M	$9.45M
Cost of Revenue	$1.01M	$939.00K	$1.22M	$1.07M	$1.22M	$1.27M
Gross Profit	$5.71M	$6.44M	$7.47M	$8.17M	$8.36M	$8.18M
Research & Development	$642.00K	$511.00K	$662.00K	$920.00K	$740.00K	$818.00K
Selling, General & Admin	$8.89M	$9.44M	$9.69M	$10.19M	$12.94M	$10.13M
Operating Expenses	$9.53M	$9.95M	$10.35M	$11.11M	$13.68M	$10.95M
Operating Income	-$3.82M	-$3.51M	-$2.88M	-$2.94M	-$5.32M	-$2.77M
EBITDA	-$3.70M	-$3.51M	-$3.04M	-$1.49M	-$5.23M	-$2.71M
Pretax Income	-$3.90M	-$3.67M	-$3.40M	-$2.98M	-$5.59M	-$3.06M
Income Tax	-$48.00K	$0.00	$0.00	$51.00K	-$321.00K	$0.00
Net Income	-$3.85M	-$3.67M	-$3.40M	-$3.04M	-$5.27M	-$3.06M
Diluted EPS	-0.47	-0.44	-0.40	—	-0.59	-0.33
Diluted Shares	8.29M	8.32M	8.45M	—	8.95M	9.40M

ECOR Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$3.78M	$3.37M	$7.86M	$7.04M	$4.85M	$8.50M
Receivables	$1.46M	$813.00K	$1.48M	$1.03M	$872.00K	$909.00K
Inventory	$1.73M	$1.43M	$1.21M	$1.63M	$1.98M	$2.42M
Current Assets	$11.97M	$10.56M	$17.35M	$15.67M	$12.53M	$14.12M
Total Assets	$16.04M	$14.56M	$21.41M	$18.67M	$15.48M	$17.06M
Current Liabilities	$7.86M	$9.62M	$12.14M	$11.35M	$12.31M	$11.67M
Long-Term Debt	—	—	$6.53M	$6.61M	$6.44M	$5.77M
Total Debt	$4.18M	$4.23M	$10.81M	$9.40M	$9.48M	$9.56M
Total Liabilities	$11.68M	$13.45M	$22.48M	$20.38M	$21.17M	$19.85M
Retained Earnings	-$180.94M	-$184.62M	-$188.02M	-$191.06M	-$196.33M	-$199.39M
Shareholders' Equity	$4.37M	$1.11M	-$1.07M	-$1.71M	-$5.69M	-$2.79M
Working Capital	$4.12M	$939.00K	$5.21M	$4.32M	$213.00K	$2.45M
Net Debt	—	—	—	—	$1.83M	—

ECOR Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	-$4.36M	-$623.00K	-$1.67M	-$1.54M	-$3.01M	-$3.52M
Capital Expenditure	-$37.00K	-$25.00K	-$4.00K	—	-$2.00K	-$4.00K
Free Cash Flow	-$4.39M	-$648.00K	-$1.67M	-$1.54M	-$3.01M	-$3.52M
Depreciation & Amortisation	$194.00K	$159.00K	$153.00K	$1.17M	$47.00K	$33.00K
Stock-Based Compensation	$540.00K	$505.00K	$415.00K	$470.00K	$1.04M	$755.00K
Investing Cash Flow	$4.50M	$185.00K	-$1.33M	$518.00K	$597.00K	$2.43M
Financing Cash Flow	$180.00K	$3.00K	$7.48M	-$40.00K	$230.00K	$4.74M
Net Change in Cash	$325.00K	-$435.00K	$4.49M	-$1.06M	-$2.18M	$3.66M

Market Snapshot

About

electroCore, Inc. is a commercial-stage bioelectronic medicine company developing non-invasive vagus nerve stimulation (nVNS) therapies. The company's gammaCore device delivers electrical stimulation through the skin to the vagus nerve in the neck, approved for treating cluster headache and migraine. electroCore's platform technology represents a drug-free approach to treating various conditions by modulating neural pathways. The company continues clinical development programs exploring additional therapeutic applications for its non-invasive neuromodulation technology.